The smart inhalers market is experiencing significant growth, driven by the increasing incidence of respiratory diseases like asthma and COPD, techno ...

DelveInsight's "INBRIJA Market Size, Forecast, and Market Insight Report" highlights the details around INBRIJA, which ...

INBRIJA, a dopamine replacement therapy for off periods in Parkinson's disease, holds significant market potential due to its ability to provide rapid relief from motor symptoms. With the increasing ...

The Trust Hospital has called for better access to inhaled medications for asthma patients in Ghana, joining the global ...

That data can be used to check that a patient is using the correct technique to get a benefit from the inhaler, for example, and give patients and healthcare providers a view of how well they are ...

Speak to your healthcare professional about switching to a greener inhaler, and return unused or unwanted inhalers to your ...

Mepolizumab, a humanized monoclonal antibody that targets interleukin-5 (IL-5), significantly reduced COPD exacerbations in ...

House Bill 46, which awaits Gov. Greg Abbott’s approval, would include more patients with chronic pain and allow for ...

Rein Therapeutics has dosed the first subject in a Phase II trial of LTI-03, its lead asset for treating idiopathic pulmonary ...

Asthma is a chronic respiratory condition that affects around 300 million people worldwide, indicating just how widespread it ...

A development economist has warned that environmental pollution combined with the soaring cost of essential medications is ...